Clinical trial
A Prospective Study of Molecular Detection of Salvageable Early Recurrent Nasopharyngeal Carcinoma After Radiotherapy
NCT03379610 is registered in ClinicalTrials.gov with The University of Hong Kong as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Prospective Study of Molecular Detection of Salvageable Early Recurrent Nasopharyngeal Carcinoma After Radiotherapy
- Lead sponsor
- The University of Hong Kong
- Phase
- Observational
- Overall status
- Completed
- Start date
- January 31, 2006
- Completion date
- December 31, 2018
- Enrollment
- 426 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.